Ro exited compounded GLP-1s in 2026 amid FDA enforcement pressure on the category Brand-name Wegovy oral pill (FDA-approved semaglutide) $149/month first month, rising to $199$299/month at higher ongoing doses Brand-name Wegovy injection/pen (FDA-approved) $199/month first month, rising to $199$399/month ongoing Brand-name Zepbound KwikPen (FDA-approved tirzepatide) $299/month first month, rising to $399$449/month ongoing Brand-name Ozempic (FDA-approved semaglutide for type 2 diabetes) insurance-dependent pricing (not independently verified this sweep) Important compliance note on compounded products Compounded semaglutide and compounded tirzepatide whether obtained through Cora Health or other telehealth platforms that offer compounded medication are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound)
The functions of L-carnitine include assisting long-chain fatty acyl-CoA across the mitochondrial membrane to promote mitochondrial -oxidation, reducing oxidative stress damage, and maintaining cellular energy homeostasis
PlexusDx does not offer branded medications but provides lower-cost, accessible alternatives through licensed compounding partners
For more information on CVS Pharmacy's GLP1 support offerings, visit www.CVS.com/GLP1
GMP Registered Facility - Our products are manufactured and formulated in USA
